Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

NCT00914927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia Related to Chronic Liver Disease

Interventions

DRUG: Avatrombopag
DRUG: Avatrombopag
DRUG: Placebo

Sponsor

Eisai Inc.